# Treatment and Outcomes of COVID-19 Infection in Pregnant Women: Systematic Review of Cases Reported in Europe

**Authors:** Radica Živković Zarić, Milan Zarić, Simona Protrka, Veljko Andrić, Neda Arsenijević, Petar Čanović, Violeta Mladenović, Stefan Jakovljević, Miljan Adamović, Miona Glišić

PMC · DOI: 10.3390/jcm14113743 · Journal of Clinical Medicine · 2025-05-27

## TL;DR

This study reviews the treatment and outcomes of pregnant women with COVID-19 in Europe, finding that most cases were mild but some required ventilation and resulted in maternal and neonatal deaths.

## Contribution

The study provides a systematic review of European case reports and series on pregnant women with COVID-19, focusing on therapies and outcomes.

## Key findings

- Most pregnant women with COVID-19 had mild symptoms like cough and fever.
- Mechanical ventilation was associated with higher neonatal mortality and more cesarean sections.
- Transplacental transmission of the virus was not significantly observed.

## Abstract

Background/Objectives: The World Health Organization (WHO) declared a global pandemic of COVID-19 caused by SARS-CoV-2 in March 2020. May 2023 was the month that ended the global pandemic. Pregnant females with COVID-19 are less likely to be symptomatic than non-pregnant patients, with nearly three-quarters being without symptoms. According to previous studies, even if somebody develops symptoms, they are usually mild, most commonly coughing (41%), fever (40%), and dyspnea (21%). Our study aims to search the literature systematically, especially case series and case reports published in Europe, and to summarize results about the kind of COVID-19 therapy in pregnant women and about outcomes in mothers and newborns. Methods: Our systematic review was registered at the International Prospective Register of Systematic Reviews (PROSPERO) with CRD42024566838. We searched PubMed/MEDLINE, Google Scholar, Web of Science, Scopus, and Serbian Citation Index (SCIndeks). In this study, case reports or case series with open, complete text that included full clinical records of the individuals identified with infection in pregnancy, thought to be caused by COVID-19, were used. Case series or case reports were eliminated if they (1) did not contain a full clinical report for every patient, or (2) included an individual who suffered from another viral infection other than COVID-19, so the clinical course and the outcome could not be precisely defined. We evaluated reporting bias and attrition bias. Results: Our study included 32 published studies (eight case series and 24 case reports) that included 56 individual cases. The oldest patient was 50 years old, and the youngest was 19 years old. The most common symptom initially was dry cough (n = 23; 41%), followed by fever (n = 21; 37%) and dyspnea (n = 10; 17%). In three patients, a lower level of thrombocytes was reported, with the lowest level of 86 × 109. The most frequently used drugs in pregnant women with COVID-19 infection were azithromycin, lopinavir/ritonavir, hydroxychloroquine, as well as corticosteroids. Twenty-two patients were on mechanical ventilation. After all this reported therapy, ten women died, as well as seven newborns. Conclusions: From our results, we can conclude that mechanical ventilation correlates with cesarean section performed more frequently, as well as with a higher mortality rate of neonates. There are no significant data related to transplacental transmission of the virus. Generally, mortality in our group of patients (mothers) was 17%, which is similar to the general population death from COVID-19 infection.

## Linked entities

- **Chemicals:** azithromycin (PubChem CID 447043), lopinavir/ritonavir (PubChem CID 11979606), hydroxychloroquine (PubChem CID 3652)
- **Diseases:** COVID-19 (MONDO:0100096), SARS-CoV-2 (MONDO:0100096)

## Full-text entities

- **Diseases:** dyspnea (MESH:D004417), COVID-19 (MESH:D000086382), viral infection (MESH:D014777), coughing (MESH:D003371), fever (MESH:D005334), infection (MESH:D007239), death (MESH:D003643)
- **Chemicals:** azithromycin (MESH:D017963), lopinavir/ritonavir (MESH:C558899), hydroxychloroquine (MESH:D006886)
- **Species:** Homo sapiens (human, species) [taxon 9606], Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12156827/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12156827/full.md

## References

66 references — full list in the complete paper: https://tomesphere.com/paper/PMC12156827/full.md

---
Source: https://tomesphere.com/paper/PMC12156827